Yes, they did, but we wanted to move as fast as the speed of science would allow, and having full autonomy over our manufacturing process was vital to be able to do that.
Subsequently, as recently as a month ago, we have undertaken a second evaluation of Canadian capabilities to understand if there's a turnkey solution for our vaccine process. After evaluating six manufacturing sites, which the government provided full capability analyses on, we determined that there was not a viable manufacturing facility here in Canada for fill-finish that would allow us to quickly transfer our process to be able to produce locally.